Replies to post #4253 on MediPharm Labs Corp (MEDIF)

[hiroller12x]

thank you for the pump Jim but i'm not worried, just a little pissed. Here to drag the sled through the sand as long as it takes to help provide for extended retirement (70 and counting lol). Confidence is over the top as it is with Valens.

Bear with me if I come off a little surly at times...I have a shorter fuse than many here. This is for my kids more than I.

Gonna stay aboard for FUNMANS response from an earlier post of mine for $15-20 in 3-5 yrs.....and I truly believe he will prove to be a clairvoyant.

Nice day in the neighborhood

[FUNMAN]

Thursday may be a cannabis day of conflict. ACB reports before the market opens. They may cast a black cloud over the sector. Hopefully the expectations are so low, that the reaction will be "ho-hum". The broader cannabis market will be waiting for Canopy.

With regards to Neptune we are super interested to hear mostly about what's happening with their Canadian operations. They have been the ugly duckling while trying to reinvent themselves.

Hopefully the Conference Call sheds lights on the Canadian numbers that most interest us. I won't be as pleased if they appear to be a weak Canadian competitor, banking on the strength and numbers coming out of their American operation.


Neptune to Report Fiscal 2020 Third Quarter Financial Results
on February 13, 2020

Laval, Québec, CANADA – January 30, 2020 – Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), announces that it will report its financial results for the fiscal 2020 third quarter before financial markets open on February 13, 2020.

Following the release its financial results, the Company will host a conference call at 8:30 AM (EST) on February 13, 2020 to discuss the third quarter financial results for the three months period ended December 31, 2019.

Conference Call Details:
Date: Thursday, February 13, 2020
Time: 8:30 AM Eastern Standard Time
Call:
1 [phone] (Canada and U.S.)
1 [phone] (International)
Conference ID: 8708188

A replay of the call will be available shortly after the call's completion and until March 13, 2020.

The replay can be accessed online in the Investors section of Neptune's website under Investor Events and Presentations.

About Neptune Wellness Solutions Inc.

Neptune Wellness Solutions specializes in the extraction, purification and formulation of health and wellness products. The Company has in excess of 100 customers across several verticals including legal cannabis and hemp, nutraceutical and consumer packaged goods. Neptune’s
wholly owned subsidiary, 9354-7537 Québec Inc., is licensed by Health Canada to process cannabis at its 50,000-square-foot facility located in Sherbrooke, Quebec. The Company also has a 24,000 square-foot facility located in North Carolina to process hemp biomass into extracts.
Neptune brings decades of experience in the natural products sector to the legal cannabis and hemp industries. Leveraging its scientific and technological expertise, the Company sees applications for hemp-derived extracts in the U.S. beyond existing markets and product forms and
into personal care and home care markets. Neptune’s activities also include the development and commercialization of turnkey nutrition solutions and patented ingredients such as MaxSimil®, and a variety of marine and seed oils. Its head office is located in Laval, Quebec.